DSpace at RU >

Browsing by Author Klijn, J.G.M.

Full Text	Issue Date	Title	Author(s)
	2010	BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.	Rijnsburger, A.J.; Obdeijn, I.M.; Kaas, R.; Tilanus-Linthorst, M.M.; Boetes, C., et al
	2007	Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?	Bresser, P.J.; Gool, A.R. van; Seynaeve, C.; Duivenvoorden, H.J.; Niermeijer, M.F., et al
	2007	A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer	Kriege, M.; Brekelmans, C.T.; Peterse, H.; Obdeijn, I.M.; Boetes, C., et al
	2007	Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.	Bresser, P.J.; Seynaeve, C.; Gool, A.R. van; Niermeijer, M.F.; Duivenvoorden, H.J., et al
	2006	Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.	Kriege, M.; Brekelmans, C.T.; Obdeijn, I.M.; Boetes, C.; Zonderland, H.M., et al
	2006	Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.	Foekens, J.A.; Atkins, D.; Zhang, Y.; Sweep, C.G.J.; Harbeck, N., et al
	2006	Decreased risk of stroke among 10-year survivors of breast cancer.	Hooning, M.J.; Dorresteijn, L.D.A.; Aleman, B.; Kappelle, A.C.; Klijn, J.G.M., et al
	2006	Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.	Kriege, M.; Brekelmans, C.T.; Boetes, C.; Muller, S.H.; Zonderland, H.M., et al
	2005	Hereditary breast cancer growth rates and its impact on screening policy.	Tilanus-Linthorst, M.M.; Kriege, M.; Boetes, C.; Hop, W.C.J.; Obdeijn, I.M., et al
	2005	Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.	Asperen, C.J. van; Brohet, R.M.; Meijers-Heijboer, E.J.; Hoogerbrugge-van der Linden, N.; Verhoef, S., et al
	2004	Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.	Dorssers, L.C.; Grebenchtchikov, N.J.; Brinkman, A.B.; Look, M.P.; Klijn, J.G.M., et al
	2004	Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.	Kriege, M.; Brekelmans, C.T.; Boetes, C.; Besnard, P.E.; Zonderland, H.M., et al
	2004	The prognostic value of BCAR1 in patients with primary breast cancer.	Dorssers, L.C.; Grebenchtchikov, N.J.; Brinkman, A.B.; Look, M.P.; Broekhoven, S.P. van, et al
	2004	Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.	Seynaeve, C.; Verhoog, L.C.; Bosch, L.M. van de; Geel, A.N. van; Menke-Pluymers, M., et al
	1997	BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients	Petrij-Bosch, A.; Peelen, T.; Vliet, M. van; Eijk, R. van; Olmer, R., et al
	1997	Prognostic value of TP53 protein accumulation in human primary breast cancer: an analysis by luminometric immunoassay on 1491 tumor cytosols	Berns, E.M.J.J.; Witte, J.H. de; Klijn, J.G.M.; Willman, K.; Look, M.P., et al
	1997	A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families	Peelen, T.; Vliet, M. van; Petrij-Bosch, A.; Mieremet, R.; Szabo, C., et al
	1996	Prognostic significance of TP53 accumulation in human primary breast cancer : comparison between a rapid quantitative immunoassay and SSCP analysis	Witte, J.H. de; Foekens, J.A.; Lennerstrand, J.A.; Smid, M.; Look, M.P., et al